According to Uzbekistan, at least 18 infants died after ingesting cough medication manufactured in India.

Following this claim, India has decided to investigate it.

The youngsters who died in Uzbekistan had eaten cough medication Doc-1 Max, manufactured by Noida-based Marion Biotech, according to a statement published by the country’s health ministry.

According to the ministry, laboratory examinations on a batch of syrups revealed the presence of ethylene glycol, a hazardous chemical.

These children, according to accounts, were given cough medication at home without a doctor’s prescription. According to reports, the cough syrup was provided to the youngsters on the recommendation of local pharmacists, and the amounts appear to have surpassed the standard amount for children.

According to the Ministry, children were administered syrup at home for 2-7 days prior to being hospitalized.

The syrup had been employed as an anti-cold medication by the children’s parents.

According to the announcement, Doc-1 Max tablets and syrups have been recalled from all pharmacies in the country following the deaths of 18 youngsters.

In addition, seven employees were fired for failing to analyze the situation and failing to take the necessary actions.

Meanwhile, a combined investigation will be carried out by teams from the Central Drugs Standard Control Organization (CDSCO – north zone) and the Uttar Pradesh Drugs Controlling and Licensing Authority, according to sources.

This is the second time this year that cough syrup made in India has come under scrutiny.